Cerulean to Host Third-Quarter 2014 Conference Call on November 13
30. Oktober 2014 08:01 ET
|
Daré Bioscience, Inc.
CAMBRIDGE, Mass., Oct. 30, 2014 (GLOBE NEWSWIRE) -- Cerulean Pharma Inc. (Nasdaq:CERU), a leader in Dynamic Tumor Targeting™, today announced it will provide an update on corporate activities...
Cerulean Appoints Vice President, Regulatory Affairs
06. Oktober 2014 09:02 ET
|
Daré Bioscience, Inc.
CAMBRIDGE, Mass., Oct. 6, 2014 (GLOBE NEWSWIRE) -- Cerulean Pharma Inc. (Nasdaq:CERU), a leader in Dynamic Tumor Targeting™, today announced the appointment of Pamela Strode as Vice President,...